This case discusses U.S. policy to allow pharmaceutical companies to run direct-to-consumer drug ads. This is focused around a National Public Radio Planet Money podcast in which the journalists do a deep dive into how the United States became one of only two countries to allow direct-to-consumer drug ads, as well as the effects that this has on consumers. This case may be discussed from a variety of angles, including marketing, sales, and communications.
This case was prepared for inclusion in SAGE Business Cases primarily as a basis for classroom discussion or self-study, and is not meant to illustrate either effective or ineffective management styles. Nothing herein shall be deemed to be an endorsement of any kind. This case is for scholarly, educational, or personal use only within your university, and cannot be forwarded outside the university or used for other commercial purposes.
2023 Sage Publications, Inc. All Rights Reserved